Quarterly report [Sections 13 or 15(d)]

Share Capital (Details)

v3.25.3
Share Capital (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Share Capital [Line Items]                    
Common stock shares outstanding (in Shares) 4,901,677   4,901,677       4,901,677      
Percentage of common shares issued and outstanding     10.00%              
Share-based compensation $ 21,476                
Share based compensation options vested     $ 408,952 $ 160,865            
Unvested stock options 214,761   $ 214,761              
Weighted average period for recognizing expense     2 years 6 months              
Grant date fair value of options granted (in Dollars per share)     $ 1.56              
Option granted (in Shares)                  
Intrinsic value of outstanding options $ 0   $ 0              
Warrants issued (in Shares)             1,077,586      
Exercise price per share (in Dollars per share)             $ 4      
Warrant balance (in Shares) 7,030   7,030              
Common Stock [Member]                    
Share Capital [Line Items]                    
Common stock shares outstanding (in Shares) 4,901,677 2,506,015 4,901,677 2,506,015 4,901,677 4,901,677 4,901,677 2,506,015 2,506,015 2,506,015